Updates are available Correction dated 2023-05-15
Click to view Correction: https://doi.org/10.1007/s00262-023-03415-5
-
Authors
Yu, Chunyan https://orcid.org/0000-0001-5501-1848
Niu, Xiulong
Du, Yongrui https://orcid.org/0000-0003-2626-0938
Chen, Yan
Liu, Xiaomei
Xu, Lingling
Iwakura, Yoichiro https://orcid.org/0000-0002-9934-5775
Ma, Xiaoxia
Li, Yan
Yao, Zhi
Deng, Weimin https://orcid.org/0000-0003-1825-2903
-
Funding
Funding for this research was provided by:
Natural Science Foundation of China (30670801)
Tianjin Natural Science Foundation (18YFZCSY00040)
Tianjin Natural Science Foundation (15JCYBJC26000)
Key projects of Tianjin Municipal Education Commission (2016YD01)
- License Information
-
More Information
Article History
Received: 27 April 2019
Accepted: 27 November 2019
First Online: 4 December 2019
Change Date: 15 May 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00262-023-03415-5
Compliance with ethical standards
:
: The authors declare that they have no conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of Tianjin Central Hospital of Gynecology Obstetrics and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards (Ethical approval number 2017KY009). All experiments with C57BL/6 mice were performed in compliance with the principles and procedures approved by the Animal Ethical and Welfare Committee (AEWC) of Tianjin Medical University (Protocol number SYXK 2016-0012).
: Informed oral consent was obtained from all individual participants included in the study. Patients consented to the use of their tumor material and clinical data for research and publication. Healthy donors also consented to the use of their tissue for research and publication.
: C57BL/6 wild-type (WT) mice were purchased from the Laboratory Animal Center of the Academy of Military Medical Sciences (Beijing, China). IL-17A<sup>−/−</sup> C57BL/6 mice were kindly provided by Hong Zhou (Nanjing Medical University, China) with permission from Yoichiro Iwakura (Tokyo University of Science, Chiba, Japan).
: Authentication is not applicable since the human OvCa cell line A2780 was purchased from KeyGEN BioTECH (Cat# KG039, Nanjing, China), OVCAR3 and SKOV3 cells were gifts from Zhi Yao (Tianjin Medical University, Tianjin, China), and the mouse ovarian epithelial papillary serous adenocarcinoma cell line ID8 was a gift from Luyuan Li (Nankai University, Tianjin, China). Hence, no authentication information was obtained.
